Skip to main content
Top

02-07-2024 | Alzheimer Disease | News

EAN 2024

Major changes needed in healthcare systems as antibodies against β-amyloid come onto the market

MedNet.nl: Over time, various drugs have been developed to treat Alzheimer's disease that target amyloid, but not always with great success. Certain antibodies against β-amyloid do show promise. The European Medicines Agency (EMA) is assessing 2 of these drugs, but what will it mean for our healthcare system if they come onto the market?

Related topics

How can you integrate PET into your practice? (Link opens in a new window)

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Register your interest

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video